Return to site

Autoimmune Disease Diagnosis Market | Growth, Trends and Forecast (2018-2022)

The autoimmune disease diagnosis market is expected to reach USD 4.73 Billion by 2022 from USD 2.85 Billion in 2016 at a CAGR of 8.9%.

· Medical Devices,Healthcare

"Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 4.73 Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%.

Factors driving the growth of this market include high incidence and large economic burden of autoimmune diseases, increasing healthcare expenditure, and growing access to medical insurance in the US.

Consumables and assay kits are estimated to account for the largest share of the market in 2017 

By product and service, the Autoimmune Disease Diagnosis Market is classified into consumables & assay kits, instruments and services. The consumables & assay kits segment is expected to lead the global autoimmune disease diagnosis in 2017. Factors driving the growth of this segment include increasing adoption of consumables in hospitals and clinical laboratories, rising incidence of autoimmune diseases, and increasing demand for quick results.
Download an Illustrative overview of the research:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174826519
 

The rheumatoid arthritis segment is expected to dominate the market in 2017 

By disease, the market is segmented into systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid disease segment is expected to account for the largest share of the global autoimmune disease diagnosis in 2017. The growth of this segment is mainly driven by the increasing incidences of the disease.

Clinical laboratories are estimated to command the largest share of the market during the forecast period 

On the basis of end user, the Autoimmune Disease Diagnosis Market is categorized into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is estimated to account for the largest share of the global Autoimmune Disease Diagnosis Market during the forecast period. The heavy burden of autoimmune diseases, along with the accessibility and availability of diagnosis and treatment instruments in clinical laboratories in a short period of time are the key factors driving the growth of this end-user segment.
North America is estimated to command the largest share of the market 
Based on region, the Autoimmune Disease Diagnosis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to dominate the Autoimmune Disease Diagnosis Market in 2017. This is attributed to factors such as accessibility to advanced technologies and opportunities for advanced autoimmune diagnostic testing and screening, growing incidence of autoimmune diseases, and technological advancements of autoimmune disease diagnosis in the region as compared to other regions.
All Posts
×

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly